Xconomy National

Archives

by in
Entry Author Date Location
FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects Arlene Weintraub 02/06/12 National
Clarus Ventures Adjusts to Unpredictable Biotech World Luke Timmerman 01/20/12 Boston
Onyx, Bayer’s Next Cancer Drug Shows Slim Survival Edge Luke Timmerman 01/17/12 San Francisco
Civitas Charts Positive Data on Inhaled Parkinson’s Drug Arlene Weintraub 01/06/12 Boston
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups Luke Timmerman 12/22/11 Seattle
Buyouts, Quantified Health, & More San Diego Life Sciences News Bruce V. Bigelow 12/01/11 San Diego
Idera Regains Cancer Drug Rights From Germany’s Merck; Stock Climbs Luke Timmerman 11/30/11 Boston
Alkermes Spinoff, Civitas, Gets Michael J. Fox Support for Inhalable Parkinson’s Drug Luke Timmerman 11/29/11 Boston
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2) Luke Timmerman 11/22/11 National
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 1) Luke Timmerman 11/21/11 National
Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News Erin Kutz 11/18/11 Boston
Eli Lilly Pumps $4M into IDRI to Continue Hunt for TB Drugs Luke Timmerman 11/17/11 Seattle
Best Buy Picks Up MindShift, Termeer Funds NanoString, Basho Adds $5M More, & More Boston-Area Deals News Erin Kutz 11/09/11 Boston
Amylin and Eli Lilly Part Ways on Diabetes Drug; Alkermes Deal Intact Bruce V. Bigelow 11/08/11 San Diego
Deals Inked for Basho, Innocentive Erin Kutz 11/03/11 Boston
Xconomist of the Week: Pfizer’s Barbara Dalton to Speak at Our NY Life Sciences 2031 Forum Arlene Weintraub 09/29/11 New York
Ambrx Grabs $24M Upfront in New Diabetes, Heart Failure Research Deal With Bristol-Myers Luke Timmerman 09/22/11 San Diego
Adimab Inks Collaboration Deals with Biogen Idec, Novo Nordisk Erin Kutz 08/29/11 Boston
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies Luke Timmerman 08/29/11 Seattle
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News Luke Timmerman 08/25/11 Seattle
Dendreon Adds Ex-ImClone CEO to Board Luke Timmerman 08/22/11 Seattle
T2 Nabs $23M, Ironwood Seeks IBS Drug Approval, FDA Sets Deadline for Alkermes Drug, & More Boston-Area Life Sciences News Erin Kutz 08/12/11 Boston
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News Bruce V. Bigelow 08/11/11 San Diego
Bydureon FDA Deadline Set Luke Timmerman 08/10/11 San Diego
Amylin & Takeda Halt Obesity Drug Development Bruce V. Bigelow 08/04/11 San Diego
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News Bruce V. Bigelow 08/04/11 San Diego
Stéphane Bancel, Former bioMérieux CEO, Talks Future of Startups, Diagnostics, Pharma Gregory T. Huang 08/04/11 Boston
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News Erin Kutz 07/29/11 Boston
Bydureon Sent Back to FDA Luke Timmerman 07/28/11 San Diego
Trius and Bayer Sign Deal, Brooks Buys Nexus Biosystems, Wildcat Discovery Gets $7.5M Financing, & More San Diego Life Sciences News Bruce V. Bigelow 07/28/11 San Diego
Page 1 of 8 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.